233 Shares in Stryker Co. (NYSE:SYK) Purchased by Westside Investment Management Inc.

Westside Investment Management Inc. acquired a new position in Stryker Co. (NYSE:SYK) in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 233 shares of the medical technology company’s stock, valued at approximately $47,000.

Other institutional investors have also made changes to their positions in the company. Bbva Compass Bancshares Inc. raised its stake in shares of Stryker by 1.1% during the 1st quarter. Bbva Compass Bancshares Inc. now owns 11,663 shares of the medical technology company’s stock worth $2,304,000 after purchasing an additional 123 shares in the last quarter. MainStreet Investment Advisors LLC raised its stake in shares of Stryker by 3.9% during the 1st quarter. MainStreet Investment Advisors LLC now owns 15,532 shares of the medical technology company’s stock worth $3,067,000 after purchasing an additional 589 shares in the last quarter. Advisory Services Network LLC raised its stake in shares of Stryker by 2.9% during the 1st quarter. Advisory Services Network LLC now owns 15,004 shares of the medical technology company’s stock worth $2,963,000 after purchasing an additional 423 shares in the last quarter. Addenda Capital Inc. raised its stake in shares of Stryker by 14.9% during the 1st quarter. Addenda Capital Inc. now owns 23,593 shares of the medical technology company’s stock worth $4,671,000 after purchasing an additional 3,060 shares in the last quarter. Finally, Hall Capital Management Co. Inc. raised its stake in shares of Stryker by 13.6% during the 1st quarter. Hall Capital Management Co. Inc. now owns 1,675 shares of the medical technology company’s stock worth $331,000 after purchasing an additional 200 shares in the last quarter. 73.26% of the stock is owned by hedge funds and other institutional investors.

SYK has been the subject of a number of recent research reports. Cantor Fitzgerald raised their price target on Stryker from $190.00 to $230.00 and gave the stock a “neutral” rating in a research note on Friday, July 26th. Deutsche Bank raised their price target on Stryker from $181.00 to $208.00 and gave the stock a “buy” rating in a research note on Wednesday, April 24th. BMO Capital Markets set a $216.00 price target on Stryker and gave the stock a “hold” rating in a research note on Friday, July 26th. Credit Suisse Group increased their price objective on Stryker from $232.00 to $237.00 and gave the company an “outperform” rating in a report on Friday, July 26th. Finally, Raymond James set a $240.00 price objective on Stryker and gave the company a “buy” rating in a report on Friday, July 26th. Five analysts have rated the stock with a hold rating and nineteen have given a buy rating to the company’s stock. Stryker presently has a consensus rating of “Buy” and a consensus target price of $214.89.

SYK traded down $1.00 during midday trading on Wednesday, reaching $210.21. The company’s stock had a trading volume of 216,163 shares, compared to its average volume of 1,070,919. The stock has a market capitalization of $79.17 billion, a PE ratio of 28.76, a P/E/G ratio of 2.57 and a beta of 0.85. The firm has a fifty day simple moving average of $207.82. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.26 and a current ratio of 2.07. Stryker Co. has a twelve month low of $144.75 and a twelve month high of $222.59.

Stryker (NYSE:SYK) last released its earnings results on Thursday, July 25th. The medical technology company reported $1.98 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.93 by $0.05. The firm had revenue of $3.65 billion for the quarter, compared to analyst estimates of $3.60 billion. Stryker had a return on equity of 25.98% and a net margin of 24.99%. The company’s revenue was up 9.9% on a year-over-year basis. During the same quarter last year, the firm posted $1.76 EPS. As a group, sell-side analysts expect that Stryker Co. will post 8.2 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 31st. Shareholders of record on Monday, September 30th will be issued a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a yield of 0.99%. The ex-dividend date of this dividend is Friday, September 27th. Stryker’s dividend payout ratio (DPR) is currently 28.45%.

In other Stryker news, insider Timothy J. Scannell sold 4,666 shares of the firm’s stock in a transaction that occurred on Tuesday, July 16th. The stock was sold at an average price of $205.88, for a total value of $960,636.08. Following the sale, the insider now owns 155,963 shares of the company’s stock, valued at approximately $32,109,662.44. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Glenn S. Boehnlein sold 2,700 shares of the firm’s stock in a transaction that occurred on Tuesday, July 30th. The shares were sold at an average price of $214.16, for a total value of $578,232.00. Following the completion of the sale, the chief financial officer now directly owns 20,633 shares in the company, valued at approximately $4,418,763.28. The disclosure for this sale can be found here. Insiders sold a total of 16,698 shares of company stock worth $3,332,432 in the last ninety days. Insiders own 7.20% of the company’s stock.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties.

Read More: What is a recession?

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Co. (NYSE:SYK).

Institutional Ownership by Quarter for Stryker (NYSE:SYK)

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.